Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-4 of 4
Keywords: Nerve growth factor
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Maria Eriksdotter-Jönhagen, Bengt Linderoth, Göran Lind, Layth Aladellie, Ove Almkvist, Niels Andreasen, Kaj Blennow, Nenad Bogdanovic, Vesna Jelic, Ahmadul Kadir, Agneta Nordberg, Erik Sundström, Lars-Olof Wahlund, Anders Wall, Maria Wiberg, Bengt Winblad, Åke Seiger, Per Almqvist, Lars Wahlberg
Dement Geriatr Cogn Disord (2012) 33 (1): 18–28.
Published Online: 22 February 2012
... Background/Aims: Degeneration of cholinergic neurons in the basal forebrain correlates with cognitive decline in patients with Alzheimer’s disease (AD). Targeted delivery of exogenous nerve growth factor (NGF) has emerged as a potential AD therapy due to its regenerative effects on the basal forebrain...
Journal Articles
Tomoyuki Nagata, Shunichiro Shinagawa, Kazutaka Nukariya, Ritsuko Nakayama, Kazuhiko Nakayama, Hisashi Yamada
Dement Geriatr Cogn Disord (2012) 32 (6): 379–386.
Published Online: 01 February 2012
...Tomoyuki Nagata; Shunichiro Shinagawa; Kazutaka Nukariya; Ritsuko Nakayama; Kazuhiko Nakayama; Hisashi Yamada Background/Aims: To address the clinical neurocognitive roles of nerve growth factor (NGF) genetic polymorphism in early-stage Alzheimer’s disease (AD) and amnestic mild cognitive...
Journal Articles
Imrich Blasko, Wolfgang Lederer, Harald Oberbauer, Thomas Walch, Georg Kemmler, Hartmann Hinterhuber, Josef Marksteiner, Christian Humpel
Dement Geriatr Cogn Disord (2005) 21 (1): 9–15.
Published Online: 15 December 2005
... on the degree of neurodegeneration (as expressed by the ratio P-tau181/Aβ42), patients with AD displayed significantly increased CSF levels of nerve growth factor (NGF) as compared to healthy controls. CSF levels of monocyte chemoattractant protein 1 (MCP-1) were found to be significantly increased with age...
Journal Articles
Maria Eriksdotter Jönhagen, Agneta Nordberg, Kaarina Amberla, Lars Bäckman, Ted Ebendal, Björn Meyerson, Lars Olson, Åke Seiger, Masahiro Shigeta, Elvar Theodorsson, Matti Viitanen, Bengt Winblad, Lars-Olof Wahlund
Dement Geriatr Cogn Disord (1998) 9 (5): 246–257.
Published Online: 19 August 1998
...Maria Eriksdotter Jönhagen; Agneta Nordberg; Kaarina Amberla; Lars Bäckman; Ted Ebendal; Björn Meyerson; Lars Olson; Åke Seiger; Masahiro Shigeta; Elvar Theodorsson; Matti Viitanen; Bengt Winblad; Lars-Olof Wahlund Nerve growth factor (NGF) is important for the survival and maintenance of central...
